In addition, we found that TG levels in HepG2 cells were not reduced by NaB intervention alone but were markedly reduced by the combination of NaB with GLP-1, suggesting that NaB alleviated hepatic steatosis partially through enhancing GLP-1 action. The gene discussed is GCG; the disease is Hepatic steatosis.